These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 39286715)

  • 1. Silymarin as an Antioxidant Therapy in Chronic Liver Diseases: A Comprehensive Review.
    Dhande D; Dhok A; Anjankar A; Nagpure S
    Cureus; 2024 Aug; 16(8):e67083. PubMed ID: 39286715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases-A comprehensive narrative review.
    Jaffar HM; Al-Asmari F; Khan FA; Rahim MA; Zongo E
    Food Sci Nutr; 2024 May; 12(5):3097-3111. PubMed ID: 38726410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review.
    Tighe SP; Akhtar D; Iqbal U; Ahmed A
    J Clin Transl Hepatol; 2020 Dec; 8(4):454-458. PubMed ID: 33447529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of silymarin in the treatment of liver diseases.
    Saller R; Meier R; Brignoli R
    Drugs; 2001; 61(14):2035-63. PubMed ID: 11735632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.
    Aghemo A; Alekseeva OP; Angelico F; Bakulin IG; Bakulina NV; Bordin D; Bueverov AO; Drapkina OM; Gillessen A; Kagarmanova EM; Korochanskaya NV; Kucheryavii UA; Lazebnik LB; Livzan MA; Maev IV; Martynov AI; Osipenko MF; Sas EI; Starodubova A; Uspensky YP; Vinnitskaya EV; Yakovenko EP; Yakovlev AA
    Ann Med; 2022 Dec; 54(1):1548-1560. PubMed ID: 35635048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review.
    Tajmohammadi A; Razavi BM; Hosseinzadeh H
    Phytother Res; 2018 Oct; 32(10):1933-1949. PubMed ID: 30015401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review.
    Mastron JK; Siveen KS; Sethi G; Bishayee A
    Anticancer Drugs; 2015 Jun; 26(5):475-86. PubMed ID: 25603021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
    Pradhan SC; Girish C
    Indian J Med Res; 2006 Nov; 124(5):491-504. PubMed ID: 17213517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silymarin: not just another antioxidant.
    Camini FC; Costa DC
    J Basic Clin Physiol Pharmacol; 2020 Mar; 31(4):. PubMed ID: 32134732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoprotective mechanism of
    Jiang G; Sun C; Wang X; Mei J; Li C; Zhan H; Liao Y; Zhu Y; Mao J
    Bioengineered; 2022 Mar; 13(3):5216-5235. PubMed ID: 35170400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytotherapy and NAFLD--from goals and challenges to clinical practice.
    Milosević N; Milanović M; Abenavoli L; Milić N
    Rev Recent Clin Trials; 2014; 9(3):195-203. PubMed ID: 25514914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report.
    Chantarojanasiri T
    Drugs Context; 2023; 12():. PubMed ID: 37077770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Descriptive Review of the Antioxidant Effects and Mechanisms of Action of Berberine and Silymarin.
    García-Muñoz AM; Victoria-Montesinos D; Ballester P; Cerdá B; Zafrilla P
    Molecules; 2024 Sep; 29(19):. PubMed ID: 39407506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapeutic potentials of milk thistle (Silybum marianum).
    Milić N; Milosević N; Suvajdzić L; Zarkov M; Abenavoli L
    Nat Prod Commun; 2013 Dec; 8(12):1801-10. PubMed ID: 24555302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.
    Federico A; Dallio M; Loguercio C
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28125040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of silymarin in patients with non-alcoholic fatty liver disease - the Siliver trial: a study protocol for a randomized controlled clinical trial.
    de Avelar CR; Nunes BVC; da Silva Sassaki B; Dos Santos Vasconcelos M; de Oliveira LPM; Lyra AC; Bueno AA; de Jesus RP
    Trials; 2023 Mar; 24(1):177. PubMed ID: 36899430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic liver disease and management with silymarin: an introductory review of a clinical case collection.
    Angelico F
    Drugs Context; 2024; 13():. PubMed ID: 38332944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milk thistle in liver diseases: past, present, future.
    Abenavoli L; Capasso R; Milic N; Capasso F
    Phytother Res; 2010 Oct; 24(10):1423-32. PubMed ID: 20564545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silymarin attenuated hepatic steatosis through regulation of lipid metabolism and oxidative stress in a mouse model of nonalcoholic fatty liver disease (NAFLD).
    Ni X; Wang H
    Am J Transl Res; 2016; 8(2):1073-81. PubMed ID: 27158393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C.
    Reddy KR; Belle SH; Fried MW; Afdhal N; Navarro VJ; Hawke RL; Wahed AS; Doo E; Meyers CM;
    Clin Trials; 2012 Feb; 9(1):102-12. PubMed ID: 22058086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.